The T348M mutated form of cryopyrin is associated with defective lipopolysaccharide-induced interleukin 10 production in CINCA syndrome
Open Access
- 1 September 2005
- journal article
- letter
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 64 (9) , 1380-1381
- https://doi.org/10.1136/ard.2004.031179
Abstract
We identified a patient with CINCA syndrome who had a T348M mutation of the cryopyrin gene using genomic DNA extracted from whole blood, as described previously.1 Because cryopyrin is largely expressed in monocytes and neutrophils, we performed functional in vitro tests using blood leucocytes of this patient (table 1) at three time points: A. medium inflammatory activity (9.59×109 blood neutrophils/l); B. high inflammatory activity (14.950×109/l); and C. low inflammatory activity (5.47×109/l). The patient did not receive immunosuppressive drug treatment except at time point C (300 mg infliximab).Keywords
This publication has 7 references indexed in Scilit:
- Inflammation-associated Cell Cycle–independent Block of Apoptosis by Survivin in Terminally Differentiated NeutrophilsThe Journal of Experimental Medicine, 2004
- Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCUBlood, 2004
- NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory DisorderPublished by Elsevier ,2004
- Calpain-1 Regulates Bax and Subsequent Smac-dependent Caspase-3 Activation in Neutrophil ApoptosisJournal of Biological Chemistry, 2004
- Use of an Anti–Interleukin-5 Antibody in the Hypereosinophilic Syndrome with Eosinophilic DermatitisNew England Journal of Medicine, 2003
- Interleukin-1–Receptor Antagonist in the Muckle–Wells SyndromeNew England Journal of Medicine, 2003
- De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal‐onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin‐associated autoinflammatory diseasesArthritis & Rheumatism, 2002